This patient had a complex phenotype, with sensory ataxia and axonal neuropathy compatible with FRDA, but in addition a severe optic atrophy, making the clinical picture more consistent with a severe OPA1 phenotype [36]. This evidence concerns the gene FXN and hereditary optic atrophy.